IGF1 and myocardial infarction: For instance, SAP hydrogel could effectively extend the release time and the anti-tumor effect of encapsulated paclitaxel in vitro (Liu et al., 2011), deliver IGF to reduce the implanted cardiomyocyte apoptosis, and promote myocardial infarction repair in vivo (Davis et al., 2006).